Korean Drug Co Ltd

014570

Company Profile

  • Business description

    Korean Drug Co Ltd is engaged in the business of manufacture and sale of pharmaceuticals. Its products include comprehensive cold remedies, hematopoietic nutrients, central nervous system agents, digestive system agents, dermatological agents, vitamins/nutritional supplements, antibiotics, antibacterials, antipyretics, analgesics, and anti-inflammatory agents. The group manufacture and sell over-the-counter medications, including Haben, Korea's cold remedy, as well as prescription drugs for various conditions, including central nervous system (CNS) diseases such as dementia, epilepsy, stroke, and Parkinson's disease.

  • Contact

    69-10 Wonjeok-ro
    Sindun-myeon
    Gyeonggi-do
    Icheon-si
    KOR

    T: +82 316347100

    https://www.nicepharma.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - General

    Fiscal Year End

    31 December 2025

    Employees

    240

Stocks News & Analysis

stocks

Overvalued ASX share as market underestimates downside risks

Growth outlook solid, but upside more than priced in.
stocks

New production imminent for undervalued ASX gas play

LNG project receives first commissioning gas.
stocks

Going into earnings, is Tesla stock a buy, a sell, or fairly valued?

Awaiting more info on robotaxis and lower cost models, here’s what we think of Tesla stock.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,324.6040.800.44%
CAC 408,189.520.930.01%
DAX 4023,830.99441.20-1.82%
Dow JONES (US)46,190.61238.370.52%
FTSE 1009,348.0188.08-0.93%
HKSE25,805.29558.192.21%
NASDAQ22,679.97117.440.52%
Nikkei 22548,995.171,413.022.97%
NZX 50 Index13,344.9655.750.42%
S&P 5006,664.0134.940.53%
S&P/ASX 2009,031.9043.700.49%
SSE Composite Index3,857.4117.660.46%

Market Movers